CareDx Files 8-K on Financials and Operations

Ticker: CDNA · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1217234

Sentiment: neutral

Topics: financial-reporting, operations, sec-filing

TL;DR

CareDx dropped an 8-K on Jan 13th covering financials & ops - check it out.

AI Summary

CareDx, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes disclosures related to Regulation FD and financial statements/exhibits. The company, formerly known as XDx, Inc. and Expression Diagnostics Inc., is incorporated in Delaware and headquartered in Brisbane, California.

Why It Matters

This 8-K filing provides crucial updates on CareDx's financial performance and operational status, which can impact investor decisions and market perception.

Risk Assessment

Risk Level: low — This filing is a standard 8-K reporting financial and operational information, not indicating any immediate or unusual risks.

Key Numbers

Key Players & Entities

FAQ

What specific financial results are being reported in this 8-K?

The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.

What is the significance of the Regulation FD Disclosure item?

It signifies that the company is making public disclosures in compliance with Regulation Fair Disclosure, ensuring broad dissemination of material information.

When did CareDx change its name from XDx, Inc.?

The date of the name change from XDx, Inc. to CareDx, Inc. was October 10, 2007.

What is the primary business of CareDx, Inc. according to its SIC code?

CareDx, Inc.'s Standard Industrial Classification (SIC) code is 8071, which corresponds to 'SERVICES-MEDICAL LABORATORIES'.

What is the address of CareDx's principal executive offices?

The principal executive offices are located at 8000 Marina Boulevard, 4th Floor, Brisbane, California 94005.

Filing Stats: 687 words · 3 min read · ~2 pages · Grade level 9.9 · Accepted 2025-01-13 07:00:18

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by CareDx, Inc., dated January 13, 2025. 99.2 Corporate Presentation of CareDx, Inc., dated January 13, 2025. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). - 2 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 CAREDX, INC. By: /s/ John W. Hanna John W. Hanna President and Chief Executive Officer - 3 -

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing